Clinical Trial

A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7806881 in Healthy Participants

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The main purpose of this study is to evaluate the safety and tolerability of single and multiple ascending doses of RO7806881 in healthy participants.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2025-11-26; most recent amendment 2026-07-21.
Status change: Not Yet Recruiting → Recruiting 2025-12-23
Trial Details
NCT Number NCT07271693
Lead Sponsor Hoffmann-La Roche
Conditions Healthy Volunteers
Enrollment 128 participants
Start Date 2025-12-22
Primary Completion 2027-03-01 (estimated)
Study Completion 2027-03-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-23